Full-Time

Histotechnologist II

Confirmed live in the last 24 hours

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions

Biotechnology
Healthcare

Compensation Overview

$85.3k - $105kAnnually

Junior, Mid

San Carlos, CA, USA

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Requirements
  • Associates degree and completion of a certified clinical program in medical laboratory sciences in histopathology or equivalent.
  • ASCP certified HT/HTL
Responsibilities
  • Preparation of tissues and stained slides of a high quality
  • Troubleshooting of technical problems related to sample preparation
  • Participation and compliance with state and federal regulations
  • Provide professional support for Clinical Trial team by means of accurate data collection, organization, and transfer
  • Performs other duties as assigned
Desired Qualifications
  • Excellent written and oral communication skills.
  • Able to accurately understand and convey information to team members.
  • Detail-oriented. Ability to think broadly about the importance of information.
  • Ability to work independently.

Natera focuses on genetic testing and diagnostics, utilizing cell-free DNA (cfDNA) testing to analyze DNA fragments in the blood for cancer detection and organ health assessment. Their technology helps identify minimal traces of cancer in patients and supports transplant patients by monitoring the health of transplanted organs. Natera also offers tests for family planning and hereditary cancer risk, including the Panorama NIPT, which has conducted over 2 million tests. The company stands out by providing specialized testing services and genetic counseling, generating revenue through testing kits and services often reimbursed by insurance.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

10%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
  • AI integration enhances accuracy and speed of Natera's cfDNA analysis.
  • Growing personalized medicine trend aligns with Natera's customized genetic tests.

What critics are saying

  • Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
  • New Prospera Heart features may face slow adoption by healthcare providers.
  • Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

What makes Natera unique

  • Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
  • Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
  • Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks